Dyne Therap 
Welcome,         Profile    Billing    Logout  
  Products    Diseases   Products    Trials    News 
4 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
DYNE-251 / Dyne Therap
2021-005478-24: Study of DYNE-251 in Participants with Duchenne Muscular Dystrophy Amenable to Exon 51 Skipping

Not yet recruiting
1/2
112
Europe
DYNE-251, DYNE-251, Solution for infusion
Dyne Therapeutics, Inc, Dyne Therapeutics, Inc
Duchenne Muscular Dystrophy, Muscular disease causing progressive loss of skeletal, pulmonary, cardiac and muscle function, Diseases [C] - Musculoskeletal Diseases [C05]
 
 
DELIVER, NCT05524883 / 2021-005478-24: Safety, Tolerability, Pharmacodynamic, Efficacy, and Pharmacokinetic Study of DYNE-251 in Participants With Duchenne Muscular Dystrophy Amenable to Exon 51 Skipping

Recruiting
1/2
88
Europe, Canada, US, RoW
DYNE-251, Placebo
Dyne Therapeutics, Dyne Therapeutics, Inc
Duchenne Muscular Dystrophy (DMD)
11/29
11/29
DYNE-101 / Dyne Therap
2022-000889-18: A clinical trial to assess safety, the possible side effects and the efficacy of DYNE-101 in patients with Myotonic Dystrophy Type 1 Uno studio clinico per valutare la sicurezza, i possibili effetti collaterali e l'efficacia di DYNE-101 in pazienti con Distrofia Miotonica di Tipo 1

Not yet recruiting
1/2
96
Europe
DYNE-101, [DYNE-101], Solution for infusion
Dyne Therapeutics, Dyne Therapeutics, Inc
Myotonic Dystrophy Type 1 Distrofia miotonica di tipo 1, Myotonic Dystrophy Type 1 Distrofia miotonica di tipo 1, Diseases [C] - Nervous System Diseases [C10]
 
 
ACHIEVE, NCT05481879 / 2022-000889-18: Safety, Tolerability, Pharmacodynamic, Efficacy, and Pharmacokinetic Study of DYNE-101 in Participants With Myotonic Dystrophy Type 1

Recruiting
1/2
104
Europe, RoW
DYNE-101, Placebo
Dyne Therapeutics, Dyne Therapeutics, Inc
Myotonic Dystrophy Type 1 (DM1)
07/26
07/26

Download Options